ema prac semaglutide naion label update 2025 Novo Nordisk refutes link between Wegovy and eye disease EMA warns Ozempic linked to

Rational decision-making favors addressing known problems over avoiding unconfirmed possibilities

[DOI] [PubMed] [Google Scholar] 179.Aroda VR, Edelstein SL, Goldberg RB, et al

Zannad F, Cannon CP, Cushman WC, et al

On clinical examination, MNTI must be distinguished from developmental cysts, odontogenic lesions (including odontoma, enameloblastoma, odontogenic myxoma and odontogenic keratocysts), non-odontogenic and non-cancerous lesions (including eosinophilic granuloma and fibrous dysplasia), and non-odontogenic benign tumors (including rhabdomyosarcoma, Hodgkins lymphoma, Langerhans cell syndrome and Ewings sarcoma)